• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APYX MEDICAL CORPORATION RENUVION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APYX MEDICAL CORPORATION RENUVION; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Device Problems Temperature Problem (3022); Patient Device Interaction Problem (4001)
Patient Problems Scar Tissue (2060); Partial thickness (Second Degree) Burn (2694)
Event Date 12/21/2021
Event Type  Injury  
Event Description
Renuvion treatment lead to severe burns and permanent scarring.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENUVION
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
APYX MEDICAL CORPORATION
MDR Report Key16911100
MDR Text Key315106108
Report NumberMW5117457
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/10/2023
Patient Sequence Number1
Treatment
ATORVASTATIN, CLIMARA PRO.; CALCIUM, D3, B12, MULTI-VITAMIN.
Patient Outcome(s) Other;
Patient Age67 YR
Patient SexFemale
Patient Weight52 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-